Federated Hermes
ARVN icon

Federated Hermes’s Arvinas ARVN Stock Holding History

Federated Hermes’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3M Buy
1,356,032
+215,317
+19% +$2.01M 0.02% 656
2026
Q1 		$12.1M Buy
1,140,715
+45,716
+4% +$566K 0.02% 582
2025
Q4 		$13M Buy
1,094,999
+414,114
+61% +$4.52M 0.02% 557
2025
Q3 		$5.8M Sell
680,885
-6,027
-0.9% -$45.7K 0.01% 707
2025
Q2 		$5.06M Sell
686,912
-293,762
-30% -$2.16M 0.01% 728
2025
Q1 		$6.88M Buy
980,674
+933,183
+1,965% +$14.6M 0.01% 637
2024
Q4 		$910K Sell
47,491
-86,719
-65% -$2.11M ﹤0.01% 1134
2024
Q3 		$3.31M Sell
134,210
-42,142
-24% -$1.1M 0.01% 819
2024
Q2 		$4.69M Buy
176,352
+4,389
+3% +$140K 0.01% 723
2024
Q1 		$7.1M Buy
171,963
+33,935
+25% +$1.48M 0.02% 641
2023
Q4 		$5.68M Buy
138,028
+33,770
+32% +$789K 0.01% 686
2023
Q3 		$2.05M Buy
+104,258
New +$2.56M 0.01% 912
2023
Q1 		– Sell
-2,190
Closed -$74.9K – 2118
2022
Q4 		$74.9K Buy
2,190
+572
+35% +$24.1K ﹤0.01% 1659
2022
Q3 		$72K Buy
1,618
+3
+0.2% +$146 ﹤0.01% 1637
2022
Q2 		$68K Buy
1,615
+1,613
+80,650% +$80.9K ﹤0.01% 1648
2022
Q1 		$1K Sell
2
-12
-86% -$818 ﹤0.01% 2062
2021
Q4 		$1K Sell
14
-60
-81% -$4.88K ﹤0.01% 2087
2021
Q3 		$6K Sell
74
-45,502
-100% -$4.02M ﹤0.01% 2025
2021
Q2 		$3.51M Sell
45,576
-15,910
-26% -$1.1M 0.01% 931
2021
Q1 		$4.06M Buy
61,486
+54,648
+799% +$4.18M 0.01% 907
2020
Q4 		$581K Sell
6,838
-7,511
-52% -$259K ﹤0.01% 1490
2020
Q3 		$339K Sell
14,349
-11,512
-45% -$334K ﹤0.01% 1569
2020
Q2 		$867K Sell
25,861
-163,283
-86% -$6.93M ﹤0.01% 1300
2020
Q1 		$7.62M Buy
189,144
+189,044
+189,044% +$8.84M 0.02% 540
2019
Q4 		$4K Buy
+100
New +$2.93K ﹤0.01% 1974

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Federated Hermes's ARVN Position: Q2 2026 in Review

Federated Hermes increased its Arvinas (ARVN) stake by 19% in Q2 2026, buying an estimated $2.01M and bringing the position to 1,356,032 shares worth $11.3M. The position accounts for 0.02% of the portfolio, ranked #656.

Federated Hermes first reported a position in ARVN in Q4 2019 and has held it in 25 quarters since. The position peaked at $13M in Q4 2025. 200 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • Federated Hermes held 1,356,032 shares of Arvinas worth $11.3M as of Q2 2026.
  • Federated Hermes bought 215,317 Arvinas shares in Q2 2026, an estimated $2.01M.
  • Arvinas made up 0.02% of Federated Hermes's portfolio in Q2 2026, its #656 holding.
  • Federated Hermes first reported a position in Arvinas in Q4 2019 and has held it in 25 quarters since.
  • Federated Hermes's Arvinas position peaked at $13M in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.